Printer Friendly

Articles from M2 Pharma (December 4, 2019)

1-23 out of 23 article(s)
Title Author Type Words
Akebia Therapeutics announces grant of stock options to 14 new employees pursuant to Nasdaq Listing Rule 5635(c)(4). 198
Allscripts issues USD200m convertible senior notes. 257
Amphivena Names Ruegg as President and CEO. 455
ARxIUM's RIVA systems achieve 10 million milestone doses. 247
Biopharma's prescription and consumer health business to be sold to STADA Group. 121
Change Healthcare reports planned departure of EVP Alex Choy. 138
CorTechs Labs Names Mirabella to Board of Directors. 297
Dr Reddy's Laboratories unveils Bortezomib for Injection 3.5 mg/vial in the US. 176
Expanded US NATETSO Partnership Between Acerus Pharmaceuticals and Aytu BioScience Is Now Fully Operational. 776
First-in-kind Human 3-Dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station. 740
KalVista Pharmaceuticals incurs higher net loss of USD5.9m for fiscal second quarter. Financial report 184
Knopp Biosciences and the University of Leicester reveal Dexpramipexole Phase two clinical trial criteria. 202
LEO Pharma partners with Portal Instruments to develop needle-free drug delivery device. 210
Merrimack announces milestone payment from Ipsen and authorises special dividend. 145
NantKwest Releases Phase 1 Results for First-in-Human PD-L1 Tumor-Targeted Natural Killer Cells (PD-L1.t-haNK) in Patients with Locally Advanced or Metastatic Solid Cancers. 509
Nektar Therapeutics names new senior vice president and chief commercial officer. 188
Novasep introduces oXYgene. 140
Phathom Pharmaceuticals Names Curran as CEO. 706
Phathom Pharmaceuticals starts phase three vonoprazan clinical trial. 180
Phathom Pharmaceuticals Starts Pivotal Phase 3 Clinical Trial for Vonoprazan in Erosive Esophagitis. 402
Revance proposes to launch public offering of common stock. 145
Sage grants stock options and performance restricted stock units under NASDAQ Listing Rule 5635(c)(4). 231
Savara welcomes An van Es-Johansson (MD) to board. 107

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters